Clinical Trial Update: S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating S-1 plus irinotecan in patients undergoing surgery for locally advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Fukushima Medical University Hospital | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN